Xponance, Inc. Tg Therapeutics, Inc. Transaction History
Xponance, Inc.
- $10.2 Billion
- Q3 2024
A detailed history of Xponance, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 8,992 shares of TGTX stock, worth $262,026. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,992Holding current value
$262,026% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding TGTX
# of Institutions
336Shares Held
87.6MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$448 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$332 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$265 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$104 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$93.4 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.23B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...